HDAX Therapeutics
HDAX Therapeutics is dedicated to developing transformative therapies targeting HDAC6 for neurological and cardiometabolic diseases. Their proprietary 2-site binding technology enhances drug efficacy, safety, and pharmacokinetics, aiming to address significant unmet medical needs. With a foundation in translational science and a strong entrepreneurial spirit, HDAX is positioned to revolutionize treatment paradigms and improve patient outcomes across multiple indications.
Something looks off?Open jobs at HDAX Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.